Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00567983
Other study ID # 13717A
Secondary ID
Status Completed
Phase Phase 4
First received December 3, 2007
Last updated September 23, 2008
Start date December 2007
Est. completion date September 2008

Study information

Verified date September 2008
Source Innovative Medical
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the effect Restasis has in regards to disease progression.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date September 2008
Est. primary completion date September 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Mild to Moderate dry eye symptoms

Exclusion Criteria:

- Current use of Restasis

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Restasis
Restasis- (in the eye) Instill one drop twice daily Endura- (in the eye) Instill one drop twice daily
Endura
Restasis- (in the eye) Instill one drop twice daily Endura- (in the eye) Instill one drop twice daily

Locations

Country Name City State
United States Lakeside Eye Clinic Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
Innovative Medical

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Disease Severity 1 yr No
Secondary Staining 1 yr No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03474692 - Virta Health Registry
Recruiting NCT05022147 - Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease Phase 1
Not yet recruiting NCT04115787 - Conservative Management in Patients Diagnosed With Grade 2 or Grade 3 CIN
Completed NCT01507415 - Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD? N/A
Completed NCT04776837 - Predicting Disease Progression and/or Recurrence in Cancer
Active, not recruiting NCT05085275 - Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease Phase 3
Completed NCT01947127 - Venous Lactate in Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients in Emergency Department N/A
Completed NCT01923103 - Natural Disease Progress of Dupuytren Disease
Active, not recruiting NCT02011932 - Prospective Observational Study of Disease Progression in Chronic Hepatitis C N/A
Not yet recruiting NCT05851209 - Biomarkers and Mechanisms of Disease Progression and Outcome of Aortic Stenosis in Humans
Withdrawn NCT02134652 - Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever N/A
Recruiting NCT02753192 - Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison N/A
Terminated NCT00338091 - Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency N/A
Completed NCT04343456 - Salvage Surgery for Patients With Metastatic GIST With Rego
Completed NCT03174912 - In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? Phase 4
Completed NCT01425073 - Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya N/A
Terminated NCT04436120 - Treatment Resistance Following Anti-cancer Therapies N/A
Terminated NCT02681809 - A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR Phase 2
Completed NCT02499068 - Madrid Project on the Management of Chronic Obstructive Pulmonary Disease With Home Telemonitoring N/A
Completed NCT05536206 - Continuous and Wireless Vital Sign Monitoring in Patients at Home After Acute Medical Admission